Follow
Nader Bagheri
Nader Bagheri
Verified email at skums.ac.ir - Homepage
Title
Cited by
Cited by
Year
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ...
The Lancet 400 (10352), 563-591, 2022
3942022
Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
M Abdollahpour‐Alitappeh, M Lotfinia, T Gharibi, J Mardaneh, ...
Journal of cellular physiology 234 (5), 5628-5642, 2019
2002019
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy
S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ...
Journal of cellular physiology 235 (1), 31-64, 2020
1282020
Comparative immune response in children and adults with H. pylori infection
A Razavi, N Bagheri, F Azadegan-Dehkordi, M Shirzad, G Rahimian, ...
Journal of immunology research 2015, 2015
982015
The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection
N Bagheri, F Azadegan-Dehkordi, H Shirzad, M Rafieian-Kopaei, ...
Microbial pathogenesis 81, 33-38, 2015
982015
Association between virulence factors of helicobacter pylori and gastric mucosal interleukin-18 mRNA expression in dyspeptic patients
N Bagheri, A Taghikhani, G Rahimian, L Salimzadeh, FA Dehkordi, ...
Microbial pathogenesis 65, 7-13, 2013
952013
Frequency of virulence factors in Helicobacter pylori-infected patients with gastritis
L Salimzadeh, N Bagheri, B Zamanzad, F Azadegan-Dehkordi, ...
Microbial pathogenesis 80, 67-72, 2015
832015
The role of T helper 1-cell response in Helicobacter pylori-infection
N Bagheri, L Salimzadeh, H Shirzad
Microbial pathogenesis 123, 1-8, 2018
822018
Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-β1 mRNA expression in gastritis patients
G Rahimian, MH Sanei, H Shirzad, F Azadegan-Dehkordi, A Taghikhani, ...
Microbial pathogenesis 67, 1-7, 2014
792014
ASSOCIATION OF THE VIRULENCE FACTORS OF HELICOBACTER PYLORI AND GASTRIC MUCOSAL INTERLEUKIN-17/23 MRNA EXPRESSION IN DYSPEPTIC PATIENTS
N Bagheri, G Rahimian, L Salimzadeh, F Azadegan, M Rafieian-Kopaei, ...
EXCLI JOURNAL 12, 5-14, 2013
712013
Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection
N Bagheri, H Shirzad, S Elahi, F Azadegan-Dehkordi, G Rahimian, ...
Microbial pathogenesis 110, 165-175, 2017
592017
Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis
Y Mokhtari, A Pourbagheri‐Sigaroodi, P Zafari, N Bagheri, SH Ghaffari, ...
Journal of Cellular and Molecular Medicine 25 (2), 639-651, 2021
562021
Up-regulated Th17 cell function is associated with increased peptic ulcer disease in Helicobacter pylori-infection
N Bagheri, A Razavi, B Pourgheysari, F Azadegan-Dehkordi, G Rahimian, ...
Infection, Genetics and Evolution 60, 117-125, 2018
552018
Toll‐like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists
A Keshavarz, A Pourbagheri‐Sigaroodi, P Zafari, N Bagheri, SH Ghaffari, ...
IUBMB life 73 (1), 10-25, 2021
542021
Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review
M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ...
Expert Opinion on Drug Safety 19 (2), 167-186, 2020
532020
Inhibition of Th1 and Th17 cells by medicinal plants and their derivatives: a systematic review
M Asadi‐Samani, N Bagheri, M Rafieian‐Kopaei, H Shirzad
Phytotherapy Research 31 (8), 1128-1139, 2017
512017
Role of regulatory T-cells in different clinical expressions of Helicobacter pylori infection
N Bagheri, F Azadegan-Dehkordi, G Rahimian, M Rafieian-Kopaei, ...
Archives of medical research 47 (4), 245-254, 2016
502016
Associations of a TLR4 single-nucleotide polymorphism with H. pylori associated gastric diseases in Iranian patients
N Bagheri, F Azadegan-Dehkordi, H Sanei, A Taghikhani, G Rahimian, ...
Clinics and research in hepatology and gastroenterology 38 (3), 366-371, 2014
482014
Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6
R Fadaei, N Bagheri, E Heidarian, A Nouri, Z Hesari, N Moradi, A Ahmadi, ...
Cytokine 125, 154832, 2020
472020
Chimeric antigen receptor based therapy as a potential approach in autoimmune diseases: how close are we to the treatment?
M Sadeqi Nezhad, A Seifalian, N Bagheri, S Yaghoubi, MH Karimi, ...
Frontiers in immunology 11, 603237, 2020
462020
The system can't perform the operation now. Try again later.
Articles 1–20